P10.04 Incidence and characteristics of neurological adverse events secondary to immunotherapy with checkpoint inhibitors
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI